Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11306513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum VEGF levels in women with a benign breast tumor or breast cancer

  2004cited by this paper
• The Role of Phosphatidylinositol 3-Kinase in Vascular Endothelial Growth Factor Signaling*

  1999cited by this paper
• VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN HUMAN PROSTATE CANCER: MORE THAN ANGIOGENESIS

  1999cited by this paper
• Vascular endothelial growth factor (VEGF) and its receptors

  1999cited by this paper
• Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

  1999cited by this paper
• Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours

  1999cited by this paper
• Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

  1999cited by this paper
• Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.

  1999cited by this paper
• Angiogenic growth factors in preinvasive breast disease.

  1999cited by this paper
• Molecular mediators of tumor angiogenesis: Enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer

  1999cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase*

  1998cited by this paper
• Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

  1998cited by this paper
• Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.

  1998cited by this paper
• Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

  1998cited by this paper
• Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily.

  1998cited by this paper
• VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix*

  1997cited by this paper
• Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

  1997cited by this paper
• AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily.

  1997cited by this paper
• Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells.

  1997cited by this paper
• Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease‐free survival

  1997cited by this paper
• Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

  1997cited by this paper
• Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

  1997cited by this paper
• Inhibition of Vascular Endothelial Growth Factor (VEGF)-induced Endothelial Cell Proliferation by a Peptide Corresponding to the Exon 7-Encoded Domain of VEGF165 *

  1997cited by this paper
• The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*)

  1996cited by this paper
• What, if anything, is an angiogenic factor?

  1996cited by this paper
• Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*)

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Vascular endothelial growth factor and its receptors.

  1996cited by this paper
• An 11-Amino Acid Sequence from c-met Initiates Epithelial Chemotaxis via Phosphatidylinositol 3-Kinase and Phospholipase C (*)

  1996cited by this paper
• Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer.

  1996cited by this paper
• Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor.

  1996cited by this paper
• Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma.

  1995cited by this paper
• VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells

  1995influential reference
• Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF.

  1995cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

  1994cited by this paper
• A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation.

  1993cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

  1992cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

  1990cited by this paper
• Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family.

  1989cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• The meaning of Scatchard and Hill plots.

  1978cited by this paper
• [13] The meaning of scatchard and hill plots

  1978cited by this paper
• Methods in Enzymology , Vol

  1966cited by this paper

• Gene expression-phenotype association study reveals the dual role of TNF-α/TNFR1 signaling axis in confined breast cancer cell migration.

  2024cites this paper
• Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions.

  2024cites this paper
• Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids

  2023cites this paper
• Evaluation of VEGF and VEGFR gene expression as prognostic markers in low and intermediate‑1 risk patients with myelodysplastic syndromes

  2023cites this paper
• In vitro evaluation of the antitumor activity of axitinib in canine mammary gland tumor cell lines

  2023cites this paper
• Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics

  2022cites this paper
• How VEGF-A and its splice variants affect breast cancer development – clinical implications

  2022cites this paper
• ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer

  2022cites this paper
• VEGFR-Mediated Cytotoxic Activity of Pulicaria undulata Isolated Metabolites: A Biological Evaluation and In Silico Study

  2021cites this paper
• Diagnostic utility of VEGF in breast lesions

  2021cites this paper
• DHA-enriched phosphatidylcholine suppressed angiogenesis by activating PPARγ and modulating the VEGFR2/Ras/ERK pathway in human umbilical vein endothelial cells

  2021cites this paper
• Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial

  2020cites this paper
• Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer

  2020cites this paper
• Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors.

  2020cites this paper
• Breast Cancer Metastasis: Are Cytokines Important Players During Its Development and Progression?

  2019cites this paper
• Phage display screening of therapeutic peptide for cancer targeting and therapy

  2019cites this paper
• Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells

  2019cites this paper
• Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.

  2019cites this paper
• Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma

  2019cites this paper
• Mechanism of metastasis suppression by luteolin in breast cancer

  2018cites this paper
• Regulation of Signal Transduction in Human Cell Research

  2018influential citation
• FGF9‐induced ovarian cancer cell invasion involves VEGF‐A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming

  2018cites this paper
• The Functional Interplay Between Pro-oncogenic RUNX2 and Hypoxia-Inducible Factor-1α (HIF-1α) During Hypoxia-Mediated Tumor Progression

  2018cites this paper
• The Clinical Significance of HPRT as a Diagnostic and Therapeutic Biomarker for Hematological and Solid Malignancies

  2018cites this paper
• INTERCELLULAR AND CELL-MATRIX INTERACTIONS IN BREAST CARCINOMA: THE PRESENT STATE OF PROBLEM

  2018cites this paper
• The expansion of targetable biomarkers for CAR T cell therapy

  2018cites this paper
• Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells

  2016cites this paper
• Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth

  2016cites this paper
• Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.

  2016cites this paper
• Antiangiogenic mechanisms and factors in breast cancer treatment

  2016cites this paper
• The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer

  2016cites this paper
• Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis

  2015cites this paper
• Cellular Plasticity, Cancer Stem Cells and Metastasis

  2015cites this paper
• The Role of Cytokines in Breast Cancer Development and Progression

  2015cites this paper
• Therapeutic and chemopreventive potential of luteolin against growth and metastasis of breast cancer

  2015influential citation
• Effects of bisphenol A and 17β-estradiol on vascular endothelial growth factor A and its receptor expression in the non-cancer and cancer ovarian cell lines

  2015cites this paper
• Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers

  2015cites this paper
• Can Anaesthetic and Analgesic Techniques for Cancer Surgery Affect Cancer Recurrence and Metastasis?

  2015cites this paper
• VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.

  2015cites this paper
• Development of an organotypic 3D in vitro model of normal human breast tissue : a tool for cancer initiation studies

  2014cites this paper
• HIF-1α Expression Correlates with Cellular Apoptosis, Angiogenesis and Clinical Prognosis in Rectal Carcinoma

  2014cites this paper
• The expression of vascular endothelial growth factor in pterygium tissue of atopic patients

  2014cites this paper
• Inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma: in vitro and in vivo studies.

  2014cites this paper
• Mead acid inhibits the growth of KPL-1 human breast cancer cells in vitro and in vivo.

  2014cites this paper
• Preparation of 99mTc carbonyl DTPA-bevacizumab and its bioevaluation in a melanoma model

  2014cites this paper
• Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts

  2014cites this paper
• D Triculture Model for Evaluating Breast Cancer Progression

  2014cites this paper
• 3 – The Cellular Microenvironment and Metastases

  2014cites this paper
• Rôle de la protéine Damaged DNA Binding 2 dans la réponse des cellules tumorales mammaires aux agents thérapeutiques

  2014cites this paper
• Ramucirumab: preclinical research and clinical development

  2014cites this paper
• Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung

  2013cites this paper
• Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells

  2013cites this paper
• Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.

  2013cites this paper
• Magnetic Resonance in the Detection of Breast Cancers of Different Histological Types

  2013cites this paper
• High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes.

  2013cites this paper
• Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.

  2013cites this paper
• Integrated Systems and Technologies EarlierDetectionofBreastCancerwithUltrasoundMolecular Imaging in a Transgenic Mouse Model

  2013cites this paper
• VEGF-Mediated Effects on Brain Microvascular Endothelial Tight Junctions and Transmigration of Breast Cancer Cells Across the Blood-Brain Barrier

  2013cites this paper
• Vascular Endothelial Growth Factor Receptor-1 Expression in Breast Cancer and Its Correlation to Vascular Endothelial Growth Factor A

  2013influential citation
• Infección peritoneal postoperatoria y recurrencia del cáncer colorrectal

  2013cites this paper
• Tumor markers in the diagnosis of cancer of the corpus uteri (a review of literature)

  2013cites this paper
• Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF

  2013cites this paper
• INFECCIÓN PERITONEAL POSTOPERATORIA Y RECURRENCIA DEL CÁNCER COLORRECTAL: ESTUDIO DE LAS RESPUESTAS INFLAMATORIA Y ANGIOGÉNICA COMO MECANISMOS RESPONSABLES DE ESTA ASOCIACIÓN

  2013cites this paper
• Infección peritoneal postoperatoria y recurrencia del cáncer colorrectal: Estudio de las respuestas inflamatoria y angiogénica como mecanismos responsables de esta asociación

  2013cites this paper
• Biochemical Basis and Therapeutic Implications of Angiogenesis

  2013cites this paper
• Tight Junctions in Cancer Metastasis

  2013cites this paper
• The soluble VEGF receptor 1 and 2 expression in cerebral spinal fluid as an indicator for leukemia central nervous system metastasis

  2013cites this paper
• Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6

  2013cites this paper
• In Vivo “MRI Phenotyping” Reveals Changes in Extracellular Matrix Transport and Vascularization That Mediate VEGF-Driven Increase in Breast Cancer Metastasis

  2013cites this paper
• Novel Anti-angiogenic Therapies Using Naturally Occurring and Synthetic Drugs to Combat Progestin-Dependent Breast Cancer

  2013cites this paper
• Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells

  2013cites this paper
• Investigating the Antiproliferative Activity of High Affinity DNA Aptamer on Cancer Cells

  2013cites this paper
• Molecular Mechanisms of Hormone Resistance of Breast Cancer

  2013cites this paper
• Endothelial Growth Factor Receptors in Angiogenesis

  2013cites this paper
• Autocrine functions of VEGF in breast tumor cells

  2012cites this paper
• Systems Analysis Of Core Architectures Regulating Cellular Responses Under Stress In Eukaryotes

  2012cites this paper
• A Non‐Mulberry Silk Fibroin Protein Based 3D In Vitro Tumor Model for Evaluation of Anticancer Drug Activity

  2012cites this paper
• Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness

  2012cites this paper
• Vascular endothelial growth factor receptor 2 (VEGFR2, Flk‐1/KDR) protects HEK293 cells against CoCl2‐induced hypoxic toxicity

  2012cites this paper
• Pazopanib for the treatment of breast cancer

  2012influential citation
• Development of drug conjugates for cancer therapy and evaluation of dual sirna silencing effect on breast cancer growth and invasion

  2012cites this paper
• Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions.

  2012cites this paper
• Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth

  2012cites this paper
• Lentivirus-mediated RNAi knockdown of VEGFA in RKO colorectal cancer cells decreases tumor formation and growth in vitro and in vivo.

  2012cites this paper
• Mesenchymal stem cell‐derived interleukin‐6 and vascular endothelial growth factor promote breast cancer cell migration

  2012influential citation
• regulatory T cells impairs mouse melanoma growth

  2012cites this paper
• Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer.

  2011cites this paper
• marrow endothelial cells of patients with multiple myeloma Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone

  2011cites this paper
• Brain Tumor Stem Cells and Anti-Angiogenic Therapy

  2011cites this paper
• Customization of tamoxifen therapy : not only a dream

  2011cites this paper
• Vascular endothelial growth factor receptors and the therapeutic targeting of angiogenesis in cancer: where do we go from here?

  2011cites this paper
• Recent advances of novel targeted therapy for squamous cell carcinoma of the head and neck

  2011cites this paper
• Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.

  2011cites this paper
• Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms

  2011cites this paper
• Hematopoietic progenitor cells (HPCs) in node-negative invasive breast carcinomas: Immunohistochemical analysis and clinico-pathological correlations.

  2011cites this paper
• Ocena ekspresji czynników regulujących angiogenezę w ostrej białaczce limfoblastycznej u dzieci

  2011cites this paper
• Prognostic impact of CD133 immunoexpression in node-negative invasive breast carcinomas.

  2011cites this paper
• Selected Aspects of Angiogensis in Haematological Malignancies

  2011cites this paper
• Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery

  2010cites this paper
• ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells

  2010cites this paper